ags-1c4d4
mAbexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2007 (NCT00519233)
Timeline
Indications
Mechanism of action
- Prostate stem cell antigenINHIBITOR
PSCA inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109548 ↗
Also known as
- ags-1c4d4
- ags-psca
- mk-4721
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01608711 | Phase 2 | Aug 7, 2012 | Agensys, Inc. |
| NCT00902291 | Phase 2 | Apr 1, 2009 | Agensys, Inc., Astellas |
| NCT00519233 | Phase 1 | Sep 1, 2007 | Agensys, Inc., Astellas |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Agensys, Inc. | For profit | 3 | 1 | 2 | 2007 |
| Astellas | For profit | 2 | 2 | 2 | 2007 |
2 organizations
Page 1 / 1